Journal of Clinical and Experimental Ophthalmology : Citations & Metrics Report
Articles published in Journal of Clinical and Experimental Ophthalmology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Experimental Ophthalmology has got h-index 80, which means every article in Journal of Clinical and Experimental Ophthalmology has got 80 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical and Experimental Ophthalmology.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
26 | 37 | 39 | 73 | 66 | 52 | 67 | 74 | 116 | 120 | 64 | 78 | 78 | 90 | 15 |
Research, Review articles and Editorials |
14 | 19 | 21 | 49 | 28 | 28 | 43 | 44 | 77 | 68 | 43 | 64 | 53 | 63 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
11 | 6 | 13 | 24 | 38 | 24 | 24 | 30 | 39 | 52 | 21 | 14 | 25 | 27 | 5 |
Conference proceedings |
19 | 13 | 3 | 65 | 19 | 65 | 274 | 261 | 443 | 128 | 111 | 69 | 21 | 19 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
1294 | 1511 | 1829 | 1912 | 1898 | 1452 | 1390 | 1420 | 1404 | 1247 | 1043 | 998 | 748 | 734 | 501 |
Journal total citations count | 22328 |
Journal impact factor | 4.57 |
Journal 5 years impact factor | 28.26 |
Journal cite score | 25.08 |
Journal h-index | 80 |
Journal h-index since 2019 | 47 |
Important citations (627)
updates on the current treatments for diabetic retinopathy and possibility of future oral therapy. |
|
different retinal expression patterns of il-1?, il-1?, and their receptors in a rat model of type 1 stz-induced diabetes. |
|
remodeling of retinal architecture in diabetic retinopathy: disruption of ocular physiology and visual functions by inflammatory gene products and pyroptosis. |
|
nod-like receptors in the eye: uncovering its role in diabetic retinopathy |
|
experimental branch retinal vein occlusion induces upstream pericyte loss and vascular destabilization |
|
deletion of thioredoxin-interacting protein (txnip) abrogates high fat diet-induced retinal leukostasis, barrier dysfunction and microvascular degeneration in a mouse obesity model. |
|
the complexity of cell composition of the intima of large arteries: focus on pericyte-like cells |
|
retina in a dish: cell cultures, retinal explants and animal models for common diseases of the retina. |
|
glaucoma pathogenesis and neurotrophins: focus on the molecular and genetic basis for therapeutic prospects. |
|
diabetic retinopathy in the spontaneously diabetic torii rat: pathogenetic mechanisms and preventive efficacy of inhibiting the urokinase-type plasminogen activator receptor system |
|
emerging insights and interventions for diabetic retinopathy |
|
p2x7 receptor antagonism: implications in diabetic retinopathy. |
|
berberine attenuates apoptosis in rat retinal müller cells stimulated with high glucose via enhancing autophagy and the ampk/mtor signaling |
|
tamoxifen toxicity in cultured retinal pigment epithelial cells is mediated by concurrent regulated cell death mechanisms. |
|
histone hist1h1c/h1.2 regulates autophagy in the development of diabetic retinopathy |
|
alterations of 5-hydroxymethylcytosines in circulating cell-free dna reflect retinopathy in type 2 diabetes |
|
oxidative stress as the main target in diabetic retinopathy pathophysiology. |
|
high glucose induces mitochondrial dysfunction in retinal müller cells: implications for diabetic retinopathy. |
|
the writers, readers, and erasers in redox regulation of gapdh. |
|
diabetic retinopathy: breaking the barrier. |
|